原发性肝癌(以下简称肝癌)严重威胁着人类的健康。而中晚期肝癌占肝癌患者的绝大多数,包括肿瘤直径≥5cm者或合并血管、胆管癌栓者或治疗后复发或肝外转移者以及合并肝功能失代偿者,治疗后其较长期生存率仍然较低。1973年至1994年我院73例中晚期肝癌患者通过肝动脉化疗栓塞(TAC Primary liver cancer (hereinafter referred to as liver cancer) is a serious threat to human health. The majority of patients with advanced liver cancer accounted for the majority of patients with liver cancer, including those with tumor diameter ≥ 5cm or with blood vessels, cholangiocarcinoma suppository or post-treatment recurrence or extrahepatic metastasis, and those with hepatic decompensation after treatment, its longer-term survival The rate is still low. Between 1973 and 1994, 73 patients with advanced liver cancer in our hospital underwent transcatheter arterial chemoembolization (TAC)